Pular para o conteúdo
Carcinoma de células escamosas esofágicas
ORPHA:99977CID-10 · C15.4CID-11 · 2B70.1DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Início adultaHerança Complex/Unknown
Também conhecida comoESCCCECCE

O carcinoma espinocelular de esôfago (CEC) é um tipo de carcinoma de esôfago (CE) que pode afetar qualquer parte do esôfago, mas geralmente está localizado no terço superior ou médio.

Última verificação: Fonte: sem afirmação sobre o SUS a verificarEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

O carcinoma de células escamosas esofágicas é um tipo de tumor maligno que afeta as paredes do esôfago, geralmente em sua parte média ou superior. Os pacientes costumam sentir dor torácica, tosse, alterações na voz e episódios de náuseas ou vômitos. Por ter origem multifatorial, a doença costuma se manifestar na idade adulta ou em pessoas idosas. No Brasil, o SUS oferece suporte por meio do PCDT de Carcinoma de Esôfago, no qual o tratamento é conduzido conforme a autonomia da equipe médica de cada serviço credenciado.

📋
Informacoes curadas por IA — podem conter imprecisoes

O carcinoma espinocelular de esôfago (CEC) é um tipo de carcinoma de esôfago (CE) que pode afetar qualquer parte do esôfago, mas geralmente está localizado no terço superior ou médio.

Pesquisas ativas
279 ensaios
691 total registrados no ClinicalTrials.gov
Publicações científicas
1.218 artigos
Último publicado: 2026 Mar 27
Medicamentos
7 com registro
DOCETAXEL, TACE, TEQUEL

Tem tratamento?

✓ 7 medicamentos específicos desta doença (registro ANVISA, FDA ou SUS/CEAF)
DOCETAXELTACETEQUELTAXOTERETAXONTASDOCETAXEL (DOCETAXEL ANHYDROUS)CONDYLOX (PODOFILOX)

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Adult
+ elderly
🏥
SUS: Cobertura mínimaScore: 0%
CID-10: C15.4
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫃
Digestivo
2 sintomas
📏
Crescimento
1 sintomas
🫁
Pulmão
1 sintomas
🦴
Ossos e articulações
1 sintomas
🩸
Sangue
1 sintomas

+ 2 sintomas em outras categorias

Características mais comuns

90%prev.
Dificuldades alimentares na infância
Muito frequente (99-80%)
90%prev.
Carcinoma esofágico
Muito frequente (99-80%)
90%prev.
Clinodactilia do quinto pododáctilo
Muito frequente (99-80%)
55%prev.
Tosse
Frequente (79-30%)
55%prev.
Dor torácica
Frequente (79-30%)
55%prev.
Anormalidade da voz
Frequente (79-30%)
8sintomas
Muito frequente (3)
Frequente (4)
Ocasional (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 8 características clínicas mais associadas, ordenadas por frequência.

Dificuldades alimentares na infânciaFeeding difficulties in infancy
Muito frequente (99-80%)90%
Carcinoma esofágicoEsophageal carcinoma
Muito frequente (99-80%)90%
Clinodactilia do quinto pododáctiloClinodactyly of the 5th toe
Muito frequente (99-80%)90%
TosseCough
Frequente (79-30%)55%
Dor torácicaChest pain
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.218PubMed
Últimos 10 anos200publicações
Pico201730 papers
Linha do tempo
2026Hoje · 2026🧪 1992Primeiro ensaio clínico📈 2017Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

4 genes identificados com associação a esta condição. Padrão de herança: Multigenic/multifactorial, Not applicable.

RNF6E3 ubiquitin-protein ligase RNF6Candidate gene tested inModerado
VIAS BIOLÓGICAS (1)
Antigen processing: Ubiquitination & Proteasome degradation
MECANISMO DE DOENÇA

Esophageal cancer

A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
38.2 TPM
Fibroblastos
35.7 TPM
Testículo
33.9 TPM
Cérebro - Hemisfério cerebelar
31.8 TPM
Cerebelo
24.3 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
esophageal canceresophageal squamous cell carcinoma
HGNC:10069UniProt:Q9Y252
TGFBR2TGF-beta receptor type-2Candidate gene tested inRestrito
VIAS BIOLÓGICAS (8)
TGF-beta receptor signaling activates SMADsDownregulation of TGF-beta receptor signalingUCH proteinasesTGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)TGFBR1 LBD Mutants in Cancer
MECANISMO DE DOENÇA

Hereditary non-polyposis colorectal cancer 6

An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
377.2 TPM
Tecido adiposo
319.8 TPM
Adipose Visceral Omentum
301.0 TPM
Mama
271.8 TPM
Nervo tibial
261.1 TPM
OUTRAS DOENÇAS (7)
Loeys-Dietz syndrome 2esophageal cancercolorectal cancer, hereditary nonpolyposis, type 6familial thoracic aortic aneurysm and aortic dissection
HGNC:11773UniProt:P37173
DLEC1Deleted in lung and esophageal cancer protein 1Candidate gene tested inTolerante
EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
42.5 TPM
Pituitária
23.6 TPM
Fallopian Tube
15.6 TPM
Pulmão
5.4 TPM
Nervo tibial
3.8 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
esophageal squamous cell carcinoma
HGNC:2899UniProt:Q9Y238
WWOXWW domain-containing oxidoreductaseMajor susceptibility factor inTolerante
VIAS BIOLÓGICAS (3)
Nuclear signaling by ERBB4Activation of the TFAP2 (AP-2) family of transcription factorsNegative regulation of activity of TFAP2 (AP-2) family transcription factors
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
13.8 TPM
Cérebro - Hemisfério cerebelar
12.1 TPM
Cerebelo
11.2 TPM
Brain Spinal cord cervical c-1
10.5 TPM
Nervo tibial
8.2 TPM
OUTRAS DOENÇAS (5)
autosomal recessive spinocerebellar ataxia 12esophageal cancerdevelopmental and epileptic encephalopathy, 28esophageal squamous cell carcinoma
HGNC:12799UniProt:Q9NZC7

Medicamentos aprovados (FDA)

2 medicamentos encontrados nos registros da FDA americana.

💊 Docetaxel (DOCETAXEL ANHYDROUS)
💊 Condylox (PODOFILOX)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

991 variantes patogênicas registradas no ClinVar.

🧬 WWOX: NM_016373.4(WWOX):c.410-2A>G ()
🧬 WWOX: NM_016373.4(WWOX):c.172+2T>G ()
🧬 WWOX: NM_016373.4(WWOX):c.529_532del (p.Val177fs) ()
🧬 WWOX: NM_016373.4(WWOX):c.746G>T (p.Arg249Leu) ()
🧬 WWOX: NM_016373.4(WWOX):c.701T>G (p.Leu234Arg) ()
Ver todas no ClinVar

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Carcinoma de células escamosas esofágicas

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 37 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

100 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

NCT07405151 · A Clinical Trial of Ifinatamab Deruxtecan in People With Adv…Recrutando
PHASE1, PHASE2🇧🇷 Brasil · 🇨🇱 Chile · 🇨🇳 China +9
NCT06780111 · Substudy 06E: Umbrella Study of Combination Therapies in Eso…Recrutando
PHASE1, PHASE2🇧🇷 Brasil · 🇨🇱 Chile · 🇨🇳 China +13
NCT06535607 · Study of Volrustomig as Monotherapy or in Combination With A…Recrutando
PHASE2🇧🇷 Brasil · 🇦🇺 Austrália · 🇨🇦 Canadá +9
NCT05319730 · A Study to Evaluate Investigational Agents With or Without P…Recrutando
PHASE1, PHASE2🇧🇷 Brasil · 🇨🇱 Chile · 🇨🇳 China +11
NCT07909031 · CR-002 in Adult Participants With Locally Advanced or Metast…Recrutando
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT07733180 · A Study Investigating Alternate Schedules of Tislelizumab Pl…Recrutando
PHASE2🇯🇵 Japão
NCT07439484 · Individually Tailored, Supervised, Remote Exercise Intervent…Recrutando
NA🇺🇸 Estados Unidos
NCT07751341 · A Clinical Study of SHR-9839 as Monotherapy or in Combinatio…Recrutando
PHASE2🇨🇳 China
NCT07730021 · A Study of ASP388B Given by Itself and With Standard Therapi…Recrutando
PHASE1, PHASE2🇯🇵 Japão · 🇺🇸 Estados Unidos
NCT07858630 · Radiotherapy Target Volume Delineation in Locally Advanced E…Recrutando
🇨🇳 China
NCT07505186 · Camrelizumab, Chemotherapy and Ivarmacitinib in Patients Wit…Recrutando
PHASE2🇨🇳 China
NCT07700667 · SKB500 Combinations in Patients With Esophageal Squamous Cel…Recrutando
PHASE2🇨🇳 China
NCT07751055 · Neoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclona…Recrutando
PHASE2🇨🇳 China
NCT07733830 · Comparing ICI Followed By CCRT And CCRT Followed By Immunoth…Recrutando
PHASE2🇨🇳 China
NCT07811752 · Sacituzumab Govitecan Combined With Tislelizumab for Locally…Recrutando
PHASE2🇨🇳 China
NCT07714538 · Breath Research Narrow Validation for Gastrointestinal Cance…Recrutando
🇬🇧 Reino Unido
NCT07697859 · PD-1 Inhibitors Combined With Local Therapy at Different Tim…Recrutando
🇨🇳 China
NCT07602842 · A Study of IDP-001 in Advanced or Metastatic Solid TumorsRecrutando
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT07638436 · Adebrelimab Combined With Neoadjuvant Chemotherapy in Border…Recrutando
PHASE2🇨🇳 China
NCT06971848 · Evaluation of Skin Tests in Biotherapy AllergiesRecrutando
NA🇫🇷 França
NCT07629817 · Surgery vs. Radical Chemoradiotherapy for Esophageal SCC Aft…Recrutando
PHASE3🇨🇳 China
NCT07554456 · A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluo…Recrutando
PHASE2, PHASE3🇨🇳 China
NCT07244978 · Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in…Recrutando
PHASE2🇨🇳 China
NCT07595770 · Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for …Recrutando
PHASE2🇨🇳 China
NCT07627347 · Efficacy and Safety of Anlotinib Combined With Bemocizumab f…Recrutando
NA🇨🇳 China
NCT07452601 · Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunoc…Recrutando
PHASE2🇨🇳 China
NCT07892833 · Becotatug Vedotin in Combination With Immunotherapy and Mult…Recrutando
PHASE2🇨🇳 China
NCT07554521 · A Study to Evaluate Efficacy and Safety of Tislelizumab Plus…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT07403136 · Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCCRecrutando
PHASE2🇨🇳 China
NCT07463573 · QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastati…Recrutando
PHASE3🇨🇳 China
NCT06828588 · Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoi…Recrutando
EARLY_PHASE1🇺🇸 Estados Unidos
NCT07484724 · A Study Evaluating the Safety and Efficacy of JS212 Combinat…Recrutando
PHASE2🇨🇳 China
NCT07519486 · Intensive Nutritional Support in Conversion Therapy for Loca…Recrutando
PHASE2🇨🇳 China
NCT07487896 · A Study of YL201 Versus Investigator's Choice of Chemotherap…Recrutando
PHASE3🇨🇳 China
NCT07246330 · Stratified Treatment in Unresectable Locally Advanced ESCC W…Recrutando
PHASE3🇨🇳 China
NCT07787273 · Interferon Gamma Plus Camrelizumab as Neoadjuvant Therapy fo…Recrutando
PHASE2🇨🇳 China
NCT07457528 · Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab…Recrutando
PHASE2🇨🇳 China
NCT07343869 · Multicenter Prospective Cohort on Esophageal Endoscopic Subm…Recrutando
🇫🇷 França
NCT07503808 · A Study of IDE034 in Adult Participants With Locally Advance…Recrutando
PHASE1Georgia · 🇪🇸 Espanha · 🇺🇸 Estados Unidos
NCT07189871 · 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally…Recrutando
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT07385001 · A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab…Recrutando
PHASE1, PHASE2🇨🇳 China
NCT07559045 · Induction Chemo-Immunotherapy + Radiotherapy vs Concurrent C…Recrutando
PHASE2🇨🇳 China
NCT07263919 · Perioperative Cadonilimab Combined With Neoadjuvant Chemothe…Recrutando
PHASE2🇨🇳 China
NCT07481058 · KC1036 in Combination With PD-1 Antibody and Platinum-based …Recrutando
PHASE2🇨🇳 China
NCT07339488 · Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for…Recrutando
PHASE2🇨🇳 China
NCT07284186 · First-in-Human Study of PLX-61639 in Locally Advanced or Met…Recrutando
PHASE1🇺🇸 Estados Unidos
NCT07530094 · Short-Course Definitive Chemoradiotherapy Combined With Adju…Recrutando
PHASE2🇨🇳 China
NCT07435454 · Exploratory Clinical Trial of Oral Paclitaxel Plus Radiother…Recrutando
PHASE2🇨🇳 China
NCT07229313 · A Study of KIVU-107 in Participants With Locally Advanced or…Recrutando
PHASE1🇦🇺 Austrália · 🇺🇸 Estados Unidos
NCT07217171 · A Study Evaluating the Safety, Efficacy, and Pharmacokinetic…Recrutando
PHASE1🇺🇸 Estados Unidos
NCT07182149 · A Phase 1 Study of NRM-823 in Participants With Locally Adva…Recrutando
PHASE1🇺🇸 Estados Unidos
NCT07796113 · Adebrelimab With Famitinib and Chemotherapy as Neoadjuvant T…Recrutando
PHASE2🇨🇳 China
NCT07205731 · Phase II Study Evaluating Safety and Efficacy of Tislelizuma…Recrutando
PHASE2🇫🇷 França
NCT07039162 · Study of Tislelizumab Combined With Chemoradiotherapy and Su…Recrutando
PHASE2🇹🇼 Taiwan
NCT07290010 · The Efficacy and Safety of Iparomlimab and Tuvonralimab Inje…Recrutando
PHASE2🇨🇳 China
NCT07109726 · A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors …Recrutando
PHASE1, PHASE2🇮🇪 Irlanda · 🇵🇹 Portugal · Puerto Rico +2
NCT07049185 · QL1706 Plus Celecoxib in Advanced Esophageal Squamous Cell C…Recrutando
PHASE2🇨🇳 China
NCT07177794 · Consolidation of Toripalimab and Capecitabine After Chemorad…Recrutando
PHASE3🇨🇳 China
NCT07152678 · Brachytherapy With Radiotherapy and Immunotherapy: Guided HD…Recrutando
PHASE2🇹🇼 Taiwan
NCT07090499 · A Study to Learn About the Study Medicine Called PF-08046876…Recrutando
PHASE1🇨🇦 Canadá · 🇨🇳 China · Puerto Rico +3
NCT07085091 · A First in Human Study of ALX2004 With Advanced or Metastati…Recrutando
PHASE1🇺🇸 Estados Unidos
NCT07061704 · Oncolytic Virus in Esophageal Squamous Cell CarcinomaRecrutando
PHASE1, PHASE2🇨🇳 China
NCT06764355 · Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followe…Recrutando
PHASE2🇹🇼 Taiwan
NCT07086469 · Surufatinib in Combination With Neoadjuvant Chemo-immunother…Recrutando
PHASE2🇨🇳 China
NCT07317609 · Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenc…Recrutando
PHASE1🇨🇳 China
NCT07188103 · Ivonescimab Plus Short-Course Hypofractionated Radiotherapy …Recrutando
PHASE2🇨🇳 China
NCT06975410 · Clinical Trial of YH32364 in Patients With Locally Advanced …Recrutando
PHASE1, PHASE2South Korea
NCT07359417 · MR-Guided Radiotherapy Dose Escalation Trial for Esophageal …Recrutando
PHASE1🇳🇱 Países Baixos
NCT06908382 · Neoadjuvant QL1706 Therapy for ESCCRecrutando
PHASE2🇨🇳 China
NCT06356688 · A Clinical Study on the Efficacy and Safety of Paclitaxel Po…Recrutando
PHASE2🇨🇳 China
NCT06912074 · Hypofractionated vs. Conventional Chemoradiotherapy After In…Recrutando
PHASE2🇨🇳 China
NCT06843889 · A Phase II Study of Toripalimab Combined With Sequential Neo…Recrutando
PHASE2🇨🇳 China
NCT06657144 · A Study of CHS-114 (Tagmokitug) in Combination With Toripali…Recrutando
PHASE1🇹🇼 Taiwan · 🇺🇸 Estados Unidos
NCT06644781 · A Study of Ifinatamab Deruxtecan in Subjects With Pretreated…Recrutando
PHASE3🇧🇪 Bélgica · 🇨🇳 China · 🇩🇰 Dinamarca +14
NCT07088354 · Deep Learning Model Predicts Pathological Complete Response …Recrutando
🇨🇳 China
NCT07266363 · Integrated Cf-miRNA and Exosomal miRNA Signature for Early D…Recrutando
🇺🇸 Estados Unidos
NCT06747585 · A Study to Investigate ALE.P02 as a Monotherapy or in Combin…Recrutando
PHASE1, PHASE2🇫🇷 França · Hong Kong · 🇮🇹 Itália +5
NCT06489197 · AK112 Combined With Chemotherapy as the First-line Treatment…Recrutando
PHASE2🇨🇳 China
NCT06709417 · A Phase II Clinical Study of Sintilimab Combined with Chemot…Recrutando
PHASE2🇨🇳 China
NCT06684600 · Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in t…Recrutando
PHASE2🇨🇳 China
NCT06637163 · Benmelstobart Combined With Radiochemotherapy as Neoadjuvant…Recrutando
PHASE2🇨🇳 China
NCT05563766 · A Phase II Trial to Evaluate the Effect of Itraconazole on P…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT06663059 · Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs …Recrutando
PHASE2🇨🇳 China
NCT06675201 · Neoantigen Vaccines in Esophageal Squamous Cell CarcinomaRecrutando
PHASE2🇨🇳 China
NCT07437898 · Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Can…Recrutando
PHASE2🇨🇳 China
NCT06561178 · Individualized Tumor-Informed CtDNA Analysis for Monitoring …Recrutando
🇨🇳 China
NCT07016724 · Neoadjuvant Radiochemotherapy Combined With Cadonilizumab fo…Recrutando
PHASE2🇨🇳 China
NCT06576973 · Adbelimumab Combined With Chemotherapy and Apatinib in Patie…Recrutando
PHASE2🇨🇳 China
NCT06545331 · Study of XB010 in Subjects With Solid TumorsRecrutando
PHASE1🇬🇧 Reino Unido · 🇺🇸 Estados Unidos
NCT06509568 · Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and …Recrutando
PHASE2🇨🇳 China
NCT06329869 · Sacituzumab Govitecan for Advanced Esophageal Squamous Cell …Recrutando
PHASE2🇹🇼 Taiwan
NCT06601309 · Biomarker Based Neoadjuvant Strategies for Locally Advanced …Recrutando
PHASE2🇨🇳 China
NCT06596954 · Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squa…Recrutando
NA🇨🇳 China
NCT06446726 · Low-dose Radiation Combined With Neoadjuvant Immunochemother…Recrutando
PHASE2🇨🇳 China
NCT07224750 · A Noninvasive and Screening miRNA Signature for Gastrointest…Recrutando
🇺🇸 Estados Unidos
NCT06452602 · Induction Immunochemotherapy Followed by Concurrent Chemorad…Recrutando
PHASE2🇨🇳 China
NCT06354140 · PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT…Recrutando
PHASE2🇨🇳 China
NCT06510660 · Adebrelimab ±Induction Chemotherapy Followed by Concurrent C…Recrutando
PHASE2🇨🇳 China
NCT06698692 · Trilaciclib for the Prevention of Chemoradiotherapy-Induced …Recrutando
🇨🇳 China
NCT06988956 · Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly…Recrutando
PHASE2🇨🇳 China

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
251 papers (10 anos)
#1

The prognostic significance of desmoplastic reaction, tumor budding and tumor-infiltrating lymphocytes in esophageal squamous cell carcinomas.

BMC gastroenterology2025 Jul 01

Recent research has demonstrated the importance of the tumor microenvironment (TME) in the behavior of solid tumors. Numerous discoveries suggest that tumor progression in a variety of malignancies, including those of the gastrointestinal tract, may be predicted by pathological evaluation of the desmoplastic reaction (DR), tumor budding (TB) and tumor-infiltrating lymphocytes (TIL). While some studies have demonstrated the prognostic impact of TIL in patients with squamous cell carcinoma of the esophagus (ESCC), the data have not reached agreement. Furthermore, few studies have investigated the relationship of DR and TB with disease progression. The relationships between DR, TB and TIL in these tumors remain to be investigated. Therefore, this study was undertaken to explore the relationships between DR, TB and TIL and histopathological parameters related to tumor behavior and assess their prognostic role in predicting survival in patients with ESCC. The retrospective case series included 98 patients diagnosed with ESCC. DR was assessed on the basis of the maturation of the tumor stroma. TB was evaluated according to the International Tumor Budding Conference (ITBCC) criteria. A semiquantitative method with a 5% threshold value was used to evaluate TIL. A significant correlation was identified between DR and sex (p = 0.023) and between DR and depth of invasion (T) (p = 0.006). TB and TIL were correlated with T (p < 0.001 and p = 0.002), lymph node metastasis (LNM) (p = 0.006 and p = 0.018), tumor stage (p < 0.001) and p = 0.003). Although DR was significantly positively correlated with TB (p < 0.001), no correlation was detected with TIL. A negative correlation between TIL and TB was also observed (p = 0.04). The results of the univariate analysis revealed significant correlations between poor survival rates and T (p < 0.001), LNM (p = 0.002), stage (p < 0.001), DR (p < 0.001), TB (p < 0.001), and TIL (p = 0.009). The multivariate analysis revealed that DR (p < 0.001), TB (p < 0.001), and T (p < 0.001) were independent prognostic factors. Our study emphasized that the assessment of DR and TB can be used to categorize individuals with ESCC for therapy and prognosis. Further research is needed to clarify the prognostic roles of TIL and their subtypes in ESCC and how they are associated with DR, depending on their association with TB.

#2

Neoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy.

Innovative surgical sciences2025 Mar

In the Western hemisphere, nonmetastatic locally advanced esophageal carcinoma is mostly treated in multimodal therapy protocols according to current therapy guidelines. In squamous cell carcinoma of the esophagus, neoadjuvant chemoradiation is the favorable option. Unimodal surgical and chemoradiation treatment alternatives show inferior results on this entity. For locally advanced adenocarcinoma of the esophagus perioperative chemotherapy and neoadjuvant chemoradiation have been competing treatment approaches in the recent past. Both are evidence based (class I evidence) and superior compared to unimodal surgery. However, the latest results of head-to-head comparative therapy studies show superior overall survival results for the FLOT regimen of perioperative chemotherapy. Furthermore, immunotherapy and targeted therapy with monoclonal antibodies have become a strong focus of current clinical research. Nivolumab as well as trastuzumab are already an important part of the current standard therapies. In both entities - SCC and AC - a significant quota of patients shows a locoregional complete remission of the tumor in the specimen after modern neoadjuvant therapy and surgical resection. The addition of immunotherapy and targeted therapy to neoadjuvant therapy further increases complete remission rates in defined subgroups according to the results of current studies. Currently, three prospective randomized trials are ongoing on the subject of future possibilities for organ-preserving concepts in case of complete clinical remission ("surgery as needed," "watch and wait"). It is to be expected for the future that curative short-term and long-term treatment results in locally advanced esophageal carcinoma will significantly improve, particularly due to the additional possibilities of immunotherapy and organ-preserving therapy concepts in postneoadjuvant complete remission.

#3

APE1 mediates chemoresistance in esophageal squamous cell carcinoma by remodeling the immunosuppressive microenvironment.

Frontiers in immunology2025

Squamous cell carcinoma of the esophagus (ESCC) has poor prognosis after surgery and adjuvant chemotherapy. Biomarkers predicting treatment efficacy are urgently needed. This study investigated apurinic/apyrimidinic endonuclease 1 (APE1), a key DNA repair enzyme, as a prognostic biomarker in ESCC patients receiving postoperative chemotherapy. To assess the relationship between APE1 expression and survival outcomes post-adjuvant chemotherapy. 115 ESCC patients receiving surgery and platinum-based chemotherapy were retrospectively enrolled. APE1 expression (low, medium, high) was determined by immunohistochemistry (IHC). Furthermore, external validation was performed using a tissue microarray cohort of 110 post-chemotherapy ESCC patients and the GES5325 dataset. Survival was analyzed using Kaplan-Meier and Cox regression. The tumor immune microenvironment was characterized by multiplex immunofluorescence (mIF). High APE1 expression correlated significantly with advanced T stage (p=0.005) and neural invasion (p=0.036). The high-expression group had significantly worse 5-year OS (27% vs. 91.4%) and DFS (14.3% vs. 55.3%) than the low-expression group (p<0.001), confirmed in public databases. Multivariate analysis identified APE1 expression (DFS: HR=4.600, 95% CI 1.285-16.466; OS: HR=16.001, 95% CI 4.826-53.061) and clinical stage as independent prognostic factors. Additionally, external validation was carried out using tissue microarrays and the GEO database to confirm the reliability. mIF analysis revealed significantly increased infiltration of FOXP3+ regulatory T cells (Treg) and cancer-associated fibroblasts (CAFs) in the APE1-high group. High APE1 expression is an independent predictor of poor prognosis in ESCC patients receiving postoperative chemotherapy, associated with Treg and CAFs-mediated immunosuppression. APE1 serves as a prognostic biomarker linked to immunosuppression, enabling personalized adjuvant therapy.

#4

Pharyngeal squamous cell carcinoma and risk of later esophageal squamous cell carcinoma - A nationwide population-based matched case-control study.

Cancer epidemiology2025 Oct

Pharyngeal squamous cell carcinoma has been linked to later squamous cell carcinoma of the esophagus, but it is unclear if risks are similar to that of Barrett's esophagus and would justify routine gastroscopy surveillance. Data on pharyngeal and esophageal cancers in 1980-2016 were retrieved through histopathology reports from Sweden's 28 pathology departments and linked to national population-based healthcare registers. We calculated hazard ratios (HRs) for esophageal cancer and death in patients with pharyngeal carcinoma compared to a matched general population, and in a secondary analysis also compared to siblings of patients. We identified 1055 adults with pharyngeal cancer without prior or concomitant cancer. 78 % were men and median age at diagnosis of pharyngeal cancer was 64 years. During a median follow-up of 2.5 years four (0.4 %) patients developed esophageal squamous cell carcinoma, equal to 1 in 263 patients (HR = 14.3; 95 % CI = 1.6-132.3). In a competing risk analysis, the risk estimate for ESCC dropped and did not attain statistical significance (subdistribution HR=1.9 (95 % CI=0.7-5.2)). Some 855 patients (81 %) died during follow-up, representing a 7.7-fold increased risk of death among patients with pharyngeal cancer (Cox regression: HR=7.7; 95 % CI = 6.8-8.6). The yearly risk of developing esophageal squamous cell carcinoma was 0.07 %. This is lower than in Barrett's esophagus and argues against long-term endoscopic surveillance among patients with pharyngeal cancer.

#5

Clinicopathologic correlations and multimodal imaging of vitreoretinal metastasis from breast carcinoma.

European journal of ophthalmology2025 Sep

PurposeTo present a case of non-uveal intraocular metastatic disease originating from relapsed breast carcinoma.MethodsWe report a 67-year-old female with a history of HER2-positive breast carcinoma in remission and recent squamous cell carcinoma of the esophagus presenting with ocular symptoms. Comprehensive ophthalmic examinations and multimodal imaging were performed. Diagnostic procedures included diagnostic vitrectomy and cytology analysis.ResultsThe patient was found to have metastatic carcinoma to the vitreous and retina with an immunophenotype compatible with breast carcinoma. Neurological symptoms led to the discovery of metastatic brain lesions. The patient underwent palliative systemic treatment and stereotactic brain irradiation. Follow-up showed the progression of the ocular lesions.ConclusionThis case informs on the clinical and pathological findings of a rare non-uveal intraocular metastatic disease originating from relapsed breast carcinoma. Vitreous biopsy and multimodal imaging were required for a proper diagnosis and management and would serve as a reference for further cases.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC609 artigos no totalmostrando 198

2025

APE1 mediates chemoresistance in esophageal squamous cell carcinoma by remodeling the immunosuppressive microenvironment.

Frontiers in immunology
2025

Pharyngeal squamous cell carcinoma and risk of later esophageal squamous cell carcinoma - A nationwide population-based matched case-control study.

Cancer epidemiology
2025

The prognostic significance of desmoplastic reaction, tumor budding and tumor-infiltrating lymphocytes in esophageal squamous cell carcinomas.

BMC gastroenterology
2025

Clinicopathologic correlations and multimodal imaging of vitreoretinal metastasis from breast carcinoma.

European journal of ophthalmology
2025

Neoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy.

Innovative surgical sciences
2025

Associations between body mass index and gastroesophageal cancer incidence and mortality: novel insights from a nationwide registry-based cohort study.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
2025

A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers.

Cancer research communications
2025

Timing of Surgery and Postoperative Outcomes in Esophagectomy for Squamous Cell Carcinoma: A Prospective Study in North India.

Journal of gastrointestinal cancer
2024

Right Ventricular Extrinsic Compression Tamponade Caused by Dilation/Necrosis of a Coloplasty Performed for Esophageal Squamous Cell Carcinoma.

Indian journal of surgical oncology
2024

Exploring the clinicopathological characteristics of submucosal tumor-like esophageal squamous cell carcinoma and the diagnostic significance of endoscopic ultrasound: a comprehensive analysis.

European journal of gastroenterology &amp; hepatology
2024

Case Report: Esophageal squamous cell carcinoma in a 13-year-old boy with a history of esophageal atresia with tracheoesophageal fistula.

Frontiers in pediatrics
2024

[Neoadjuvant therapy of locally advanced squamous cell carcinoma of the esophagus : Radiochemotherapy vs. doublet or triplet chemotherapy alone].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
2024

Squamous Cell Carcinoma of the Esophagus in an Adolescent: A Case Report.

Cureus
2024

Paclitaxel/Ramucirumab versus Paclitaxel in 2nd-Line Therapy of Advanced Esophageal Squamous Cell Carcinoma: Randomized Phase II IKF-AIO-RAMOS Trial.

Oncology research and treatment
2024

The role of length of oral resection margin and survival in esophageal cancer surgery after neoadjuvant therapy: A retrospective propensity score-matched study.

Surgery
2024

Treatment of patients with carcinomas in advanced stages with 5-fluorouracil, folinic acid and pyridoxine in tandem.

Scientific reports
2024

Purulent Pericarditis as the First Manifestation of Esophageal Carcinoma.

Portuguese journal of cardiac thoracic and vascular surgery
2025

Leiomyosarcoma of the esophagus, arising from lamina muscularis mucosae, in a combination with microinvasive squamous cell carcinoma-A case report.

Indian journal of pathology &amp; microbiology
2024

Pembrolizumab for recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus: a drug safety evaluation.

Expert opinion on drug safety
2025

Atypical intrapapillary capillary loops in early-stage basaloid squamous cell carcinoma of the esophagus.

Revista espanola de enfermedades digestivas
2024

Simultaneous presentation and resection of esophageal cancer and metastasis to the pancreas: Α case report and literature review.

Molecular and clinical oncology
2024

Carbon dioxide gas-induced pneumothorax versus one-lung ventilation in minimally invasive esophagectomy: a multicenter propensity score matching cohort study.

International journal of surgery (London, England)
2023

HOXC10 promotes esophageal squamous cell carcinoma progression by targeting FOXA3 and indicates poor survival outcome.

Heliyon
2023

Trends in Epidemiology of Esophageal Cancer in the US, 1975-2018.

JAMA network open
2023

Refractory Lactic Acidosis and Hypoglycemia in a Patient With Metastatic Esophageal Cancer Due to the Warburg Effect.

Cureus
2023

Metachronous Squamous Cell Carcinoma of the Esophagus After Resolution of Previous Adenocarcinoma.

ACG case reports journal
2023

OPLAH Protein Expression Stratifies the Prognosis of Patients With Squamous Cell Carcinoma of the Esophagus.

Cancer genomics &amp; proteomics
2023

Role of Confocal Laser Endomicroscopy in Early Detection of Upper Gastrointestinal Malignancy in High Risk Patients.

Asian Pacific journal of cancer prevention : APJCP
2023

Increasing access to pathology services in low- and middle-income countries through innovative use of telepathology.

Surgical endoscopy
2023

A novel diagnostic signature of circulating tsRNAs and miRNAs in esophageal squamous cell carcinoma detected with a microfluidic platform.

Analytica chimica acta
2023

Colloid gastric emptying with SPECT-CT after oesophagectomy.

JPMA. The Journal of the Pakistan Medical Association
2023

DOES NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL AND GASTROESOPHAGEAL JUNCTION CANCER PATIENTS AFFECT POSTOPERATIVE OUTCOMES? A STUDY USING THE BECKER TUMOR REGRESSION GRADE SYSTEM AND LYMPH NODE REGRESSION.

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
2023

Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy.

Esophagus : official journal of the Japan Esophageal Society
2023

The effect of Andrographis paniculata water extract on palliative management of metastatic esophageal squamous cell carcinoma-A phase II clinical trial.

Phytotherapy research : PTR
2023

A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2.

BMC cancer
2023

Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderly.

Frontiers in oncology
2023

Diffusely infiltrative squamous cell carcinoma of the esophagus resembling scirrhous gastric cancer: a case report.

Annals of medicine and surgery (2012)
2023

Long‑term prognosis and comprehensive endoscopic treatment strategy for esophageal cancer, including salvage endoscopic treatment after chemoradiation therapy.

Experimental and therapeutic medicine
2023

Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma.

BMC cancer
2022

Definitive radiation therapy with dose escalation is beneficial for patients with squamous cell cancer of the esophagus.

Journal of cancer research and therapeutics
2023

Identification of a Novel GRHL3/HOPX/Wnt/β-Catenin Proto-oncogenic Axis in Squamous Cell Carcinoma of the Esophagus.

Cellular and molecular gastroenterology and hepatology
2022

Airway Management of a Patient With Tracheoesophageal Fistula and Tracheal Stent.

Cureus
2022

A Case Report of Rare Synchronous Esophageal Malignancies With Dissimilar Histology: Squamous Cell Carcinoma and Small Cell Carcinoma.

Cureus
2022

Hub Genes and Long Noncoding RNAs That Regulates It Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.

Computational and mathematical methods in medicine
2022

Squamous Cell Carcinoma of the Esophagus.

Gastroenterology clinics of North America
2023

Endoscopic stent placement after spontaneous esophageal perforation associated with chemoradiotherapy for esophageal cancer.

Revista espanola de enfermedades digestivas
2022

Adjuvant Chemotherapy for Pathological Node-Positive Disease in Squamous Cell Carcinoma of the Esophagus after Neoadjuvant Chemoradiotherapy Plus Surgery.

Journal of personalized medicine
2022

Commentary: Squamous cell carcinoma of the esophagus: Another target for checkpoint inhibition.

JTCVS open
2022

Endoscopic submucosal dissection for early esophageal squamous cell carcinoma with esophageal-gastric fundal varices caused by liver cirrhosis: a case report.

Translational cancer research
2023

A diagnostic pitfall; Small cell carcinoma-like features in basaloid squamous cell carcinoma of the esophagus.

Histology and histopathology
2022

eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma.

Journal of translational medicine
2022

Constrictive pericarditis caused by pericardial metastasis from esophageal squamous cell carcinoma: a case report.

International cancer conference journal
2022

First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590.

Esophagus : official journal of the Japan Esophageal Society
2022

Cutaneous metastasis from esophageal squamous cell carcinoma: A case report.

World journal of clinical cases
2022

Efficacy of thoracotomy and thoracoscopic-assisted esophageal surgery in conversion and salvage surgeries: a retrospective study.

World journal of surgical oncology
2022

Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck.

Frontiers in medicine
2022

A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute.

Cancers
2022

THE PROGNOSIS OF THE DIFFERENT ESOPHAGEAL NEUROENDOCRINE CARCINOMA SUBTYPES: A POPULATION-BASED STUDY.

Arquivos de gastroenterologia
2022

Esophageal carcinoma as a portal of entry for brainstem abscess formation.

Acta gastro-enterologica Belgica
2022

Life Expectancy in Survivors of Esophageal Cancer Compared with the Background Population.

Annals of surgical oncology
2022

MicroRNAs and Corresponding Targets in Esophageal Cancer as Shown In Vitro and In Vivo in Preclinical Models.

Cancer genomics &amp; proteomics
2022

Update on Management of Squamous Cell Esophageal Cancer.

Current oncology reports
2022

Synchronous esophageal squamous cell carcinoma and hepatocellular carcinoma: A rare case report.

Radiology case reports
2022

NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY TRANSHITAL ESOPHAGECTOMY IN LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: IMPACT OF PATHOLOGICAL COMPLETE RESPONSE.

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
2022

Bayesian post-hoc analysis of chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

The Journal of thoracic and cardiovascular surgery
2021

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial.

Contemporary clinical trials communications
2021

Clinico-epidemiological profile and treatment outcomes in patients with squamous cell carcinoma of the esophagus following docetaxel-based neoadjuvant chemotherapy: experience from a cancer care center in Northeast India.

Journal of the Egyptian National Cancer Institute
2021

Atypical Presentation of Esophageal Squamous Cell Carcinoma Masquerading as Diffuse Severe Esophagitis.

Case reports in gastroenterology
2021

A Rare Case of Esophageal Leukoplakia: A Potential Precursor to Esophageal Malignancy.

Cureus
2022

Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
2021

Comparative Analysis of Clinicopathological Characteristics, Survival Features, and Protein Expression Between Basaloid and Squamous Cell Carcinoma of the Esophagus.

International journal of general medicine
2022

Treatment strategies and outcomes for elderly patients with locally advanced squamous cell carcinoma of the esophagus.

Surgery today
2021

Bulimia Nervosa Leading to Squamous Cell Carcinoma of the Esophagus in a Young Adult.

Cureus
2021

Esophageal basaloid squamous cell carcinoma presenting as a subepithelial lesion.

Clinical journal of gastroenterology
2021

Ethiopian Medicinal Plants Traditionally Used for the Treatment of Cancer; Part 3: Selective Cytotoxic Activity of 22 Plants against Human Cancer Cell Lines.

Molecules (Basel, Switzerland)
2021

Pharmacologic modulation of 5-fluorouracil by folinic acid and high-dose pyridoxine for treatment of patients with digestive tract carcinomas.

Scientific reports
2021

Role of chemotherapy after curative esophagectomy in squamous cell carcinoma of the thoracic esophagus: A propensity score-matched analysis.

Thoracic cancer
2021

Prevalence of HER2 overexpression and amplification in squamous cell carcinoma of the esophagus: A systematic review and meta-analysis.

Critical reviews in oncology/hematology
2021

Intratumoral Metabolic Heterogeneity and Other Quantitative 18F-FDG PET/CT Parameters for Prognosis Prediction in Esophageal Cancer.

Radiology. Imaging cancer
2021

Where to Start and What to Do Next: The Sequencing of Treatments in Metastatic Esophagogastric Cancer.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
2021

TRANSHIATAL ESOPHAGECTOMY IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS: WHAT ARE THE BEST INDICATIONS?

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
2021

Pembrolizumab as a first-line therapy in spinocellular esophageal cancer.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
2021

Esophageal Cancer: An Updated Review.

Southern medical journal
2021

Beyond Squamous Cell Carcinoma: Basaloid Squamous Cell Carcinoma of the Esophagus.

Cureus
2021

Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach.

Cancer imaging : the official publication of the International Cancer Imaging Society
2021

Kissing tumors; the concurrent diagnosis of leiomyosarcoma and squamous cell carcinoma of the esophagus.

BMC surgery
2020

A Pseudo-Infarction Pattern in the Setting of Esophageal Malignancy.

Cureus
2020

Histological criteria for "intraepithelial squamous cell carcinoma" of the esophagus: continued dialogue between Ukrainian and Japanese pathologists.

Experimental oncology
2021

Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy.

Annals of surgical oncology
2020

Palliative care for patients with esophageal cancer: a narrative review.

Annals of translational medicine
2020

Intramucosal squamous cell carcinoma of the esophagus: is surgery still an option?

Endoscopy
2020

Three-dimensional computed tomography image-oriented successful thoracoscopic subtotal esophagectomy for an esophageal cancer patient with an anomalous right superior pulmonary vein: A case report.

International journal of surgery case reports
2020

A Rare Case of Erythema Gyratum Repens Associated With Esophageal Carcinoma.

Cureus
2020

Targeted Therapies in Advanced Gastric Cancer.

Current treatment options in oncology
2021

Newly developed primary malignancies in long-term survivors who underwent curative esophagectomy for squamous cell carcinoma of the esophagus.

Surgery today
2020

Different response rates to chemotherapy between Japanese and German esophageal squamous cell carcinoma: patients may be influenced by ERCC1 or ABCB1.

Future oncology (London, England)
2021

Total Lesion Glycolysis Ratio in Positron Emission Tomography/Computed Tomography Images During Neoadjuvant Chemotherapy Can Predict Pathological Tumor Regression Grade and Prognosis in Patients with Locally Advanced Squamous Cell Carcinoma of the Esophagus.

Annals of surgical oncology
2020

An Open-Label Single-Arm Phase II Study of Treatment with Neoadjuvant S-1 Plus Cisplatin for Clinical Stage III Squamous Cell Carcinoma of the Esophagus.

The oncologist
2020

Cervical squamous cell carcinoma coexisting with ectopic gastric mucosa treated by endoscopic submucosal dissection: A case report.

Molecular and clinical oncology
2020

A Monocentric, Retrospective Analysis of 61 Patients with Generalized Granuloma Annulare.

Dermatology (Basel, Switzerland)
2020

Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI.

Acta oncologica (Stockholm, Sweden)
2020

Acute treatment-related toxicity in elderly patients with good performance status compared to young patients in locally advanced esophageal carcinoma treated by definitive chemoradiation: A retrospective comparative study.

Journal of cancer research and therapeutics
2021

Long-term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive chemoradiotherapy.

Surgical endoscopy
2020

[Squamous cell carcinoma of the esophagus-two-field or three-field lymphadenectomy?].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
2020

Hemorrhagic Shock Secondary to Aortoesophageal Fistula as a Complication of Esophageal Cancer.

Cureus
2020

Definitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable disease.

Journal of radiation research
2020

[Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
2020

Isolated tumor cells in the regional lymph nodes in patients with squamous cell carcinoma of the esophagus are rarely observed but often represent part of a true metastasis.

Annals of diagnostic pathology
2020

Anesthetic Management for Squamous Cell Carcinoma of the Esophagus.

Methods in molecular biology (Clifton, N.J.)
2018

Roundabout1 distribution in neoplastic and non-neoplastic diseases with a focus on neoangiogenesis.

International journal of clinical and experimental pathology
2019

Long-term complete response in supraclavicular lymph node metastases of esophageal cancer using systemic chemotherapy-a case report.

International journal of clinical and experimental pathology
2020

Cost-effectiveness of chemoradiation followed by esophagectomy versus chemoradiation alone in squamous cell carcinoma of the esophagus.

Cancer medicine
2019

Multiple primary cancers in patients treated for squamous cell carcinoma of the esophagus.

Polski przeglad chirurgiczny
2020

Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.

Annals of surgical oncology
2019

Early administration of pegfilgrastim for esophageal cancer treated with docetaxel, cisplatin, and fluorouracil: A phase II study.

Cancer science
2019

The Evolving Landscape of Esophageal Cancer: A Four-Decade Analysis.

The American surgeon
2019

A Rare Case of Squamous Cell Carcinoma of the Esophagus in a Patient With Goltz Syndrome.

ACG case reports journal
2019

Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus.

Annals of surgical oncology
2019

Comparison of the therapeutic effects of endoscopic submucosal dissection and minimally invasive esophagectomy for T1 stage esophageal carcinoma.

Thoracic cancer
2020

Esophagectomy for the patients with squamous cell carcinoma of the esophagus after allogeneic hematopoietic stem cell transplantation.

International journal of clinical oncology
2019

[Successful Multidisciplinary Treatment Accomplished by Collaboration of Multiple Clinical Departments for Synchronous Quadruple Cancer].

Kyobu geka. The Japanese journal of thoracic surgery
2020

Association between macrocytosis and metachronous squamous cell carcinoma of the esophagus after endoscopic resection in men with early esophageal squamous cell carcinoma.

Esophagus : official journal of the Japan Esophageal Society
2019

Does a Lymph Node-Based Model Predict Clinical Value for Adjuvant Therapy in Squamous Cell Carcinoma of the Esophagus Treated With Upfront Surgery?

Annals of surgical oncology
2019

Uncommon Endoscopic Findings in a Tylosis Patient: A Case Report.

Case reports in oncology
2019

Endoscopic features and associated histology of an basaloid squamous cell carcinoma of the esophagus at the very early stage.

BMC cancer
2019

Evolving screening and surveillance techniques for Barrett's esophagus.

World journal of gastroenterology
2019

Endoscopic resection for early esophageal carcinoma.

Journal of thoracic disease
2019

Acute Dysphagia Caused by Sarcomatoid Squamous Cell Carcinoma of the Esophagus.

Cureus
2019

Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus.

Radiation oncology (London, England)
2019

Successful definitive concurrent chemoradiotherapy in a patient with esophageal cancer and Child-Pugh B cirrhosis of the liver.

Journal of cancer research and therapeutics
2019

Association of a genetic variant in ATP-binding cassette sub-family B member 1 gene with poor prognosis in patients with squamous cell carcinoma of the esophagus.

IUBMB life
2019

Interpreting the Survival Benefit From Neoadjuvant Chemoradiotherapy Before Surgery for Locally Advanced Squamous Cell Carcinoma of the Esophagus.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2019

Bronchoscopic cryosurgery for metastatic tumor causing central airway obstruction: A case report.

Medicine
2019

Novel use of proton beam therapy for neoadjuvant treatment of radiation-associated squamous cell carcinoma of the esophagus.

Journal of gastrointestinal oncology
2019

Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results.

Oncotarget
2019

KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer.

Future oncology (London, England)
2019

Impact of isolated tumor cells in regional lymph nodes in adeno-and squamous cell carcinoma of the esophagus and the esophagogastric junction-A systematic review.

Pathology, research and practice
2019

Radiation With Neoadjuvant Chemotherapy Does Not Improve Outcomes in Esophageal Squamous Cell Cancer.

The Journal of surgical research
2019

Effect of STAT3 decoy oligodeoxynucleotides mediated by ultrasound-targeted microbubbles combined with ultrasound on the growth of squamous cell carcinoma of the esophagus.

Oncology letters
2018

Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus: the (NEOCRTEC5010) trial-a timely and welcome clinical trial from the Far East.

Journal of thoracic disease
2019

[Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and resection for squamous cell carcinoma of the esophagus].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
2019

Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study.

JAMA oncology
2018

PATHOLOGIC COMPLETE RESPONSE (YPT0 YPN0) AFTER CHEMOTHERAPY AND RADIOTHERAPY NEOADJUVANT FOLLOWED BY ESOPHAGECTOMY IN THE SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS.

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
2019

Use of curcumin solution for probe-based confocal laser endomicroscopy of squamous cell carcinoma of the esophagus.

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
2018

Expression of vasohibin-1 and -2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus.

Oncology letters
2018

Cancers Due to Smoking and High Alcohol Consumption.

Deutsches Arzteblatt international
2018

Effects of Spinal-Z in Patients with Gastroesophageal Cancer.

Journal of pharmacopuncture
2018

Endoscopic or Surgical Resection for Gastro-Esophageal Cancer.

Deutsches Arzteblatt international
2018

Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2018

Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus.

Radiation oncology (London, England)
2018

Synchronous triple squamous cell carcinoma of the esophagus.

International journal of surgery case reports
2018

Esophageal cancer associated with a sarcoid-like reaction and systemic sarcoidosis in lymph nodes: supportive findings of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography during neoadjuvant therapy.

Surgical case reports
2019

Refractory Hypercalcemia in Squamous Cell Carcinoma of the Esophagus-a Case Report and Review of Literature.

Journal of gastrointestinal cancer
2018

The Clinical Implications of Death Domain-Associated Protein (DAXX) Expression.

The Korean journal of thoracic and cardiovascular surgery
2018

Phase I/II Trial of Chemotherapy with Docetaxel, Cisplatin, and S-1 for Unresectable Advanced Squamous Cell Carcinoma of the Esophagus.

Oncology
2018

Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma.

Anesthesia and analgesia
2017

Endovascular Treatment of Carotid Blowout Syndrome.

Revista portuguesa de cirurgia cardio-toracica e vascular : orgao oficial da Sociedade Portuguesa de Cirurgia Cardio-Toracica e Vascular
2018

MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus.

Journal of translational medicine
2018

A genetic polymorphism in the CYP1B1 gene in patients with squamous cell carcinoma of the esophagus: an Iranian Mashhad cohort study recruited over 10 years.

Pharmacogenomics
2018

The Infection Returns: A Case of Pulmonary Sporotrichosis Relapse after Chemotherapy.

Case reports in medicine
2018

Endoscopic submucosal tunnel dissection for early squamous cell carcinoma of the esophagus.

Endoscopy
2017

Stereotactic body radiotherapy for oligo-recurrence in the liver in a patient with esophageal carcinoma: A case report.

Molecular and clinical oncology
2017

Extranodal extension of nodal metastasis is the main prognostic moderator in squamous cell carcinoma of the esophagus after neoadjuvant chemoradiotherapy.

Journal of thoracic disease
2018

An analysis of the risk factors of anastomotic stricture after esophagectomy.

Surgery today
2017

Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus.

Radiation oncology (London, England)
2018

Endoscopic submucosal dissection of a squamous cell carcinoma of the esophagus developing in the area of a previous Heller's myotomy for achalasia.

Endoscopy
2017

Overall Survival of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Treated with Nimotuzumab in the Real World.

Advances in therapy
2018

Comparative Analysis of Clinical, Treatment, and Survival Characteristics of Basaloid and Squamous Cell Carcinoma of the Esophagus.

Journal of the American College of Surgeons
2018

With or without consolidation chemotherapy using cisplatin/5-FU after concurrent chemoradiotherapy in stage II-III squamous cell carcinoma of the esophagus: A propensity score-matched analysis.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
2017

Identification of NCCRP1 as an epigenetically regulated tumor suppressor and biomarker for malignant phenotypes of squamous cell carcinoma of the esophagus.

Oncology letters
2019

Subcutaneous metastasis from recurrent basaloid squamous cell carcinoma of the esophagus.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
2017

Continuous intraoperative vagus nerve stimulation for monitoring of recurrent laryngeal nerve during minimally invasive esophagectomy.

Journal of visualized surgery
2017

CYFRA 21-1 as a tumor marker for squamous cell carcinoma of the esophagus.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
2017

A Case of Basaloid Squamous Cell Carcinoma of Polypoid Type in the Esophagus.

Case reports in gastroenterology
2017

The importance of the concept and histological criteria of "intraepithelial squamous cell carcinoma" of the esophagus: in comparison between Western and Japanese criteria.

Esophagus : official journal of the Japan Esophageal Society
2017

Combination of c-reactive protein and squamous cell carcinoma antigen in predicting postoperative prognosis for patients with squamous cell carcinoma of the esophagus.

Oncotarget
2017

A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.

BMC cancer
2017

Treatment of Squamous Cell Carcinoma of the Esophagus Synchronously Associated with Head and Neck Cancer.

In vivo (Athens, Greece)
2017

Clinicopahological features of superficial basaloid squamous cell carcinoma of the esophagus.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
2017

Prevalence of Squamous Cell Carcinoma of the Esophagus in a Single Tertiary Center of South Africa: A Cross Sectional Analytic Study.

Journal of public health in Africa
2018

The Significance of SCC and CEA mRNA in the Pleural Cavity After Lymphadenectomy in Esophageal Cancer Patients who Underwent Preoperative Treatment.

World journal of surgery
2018

SOX2-silenced squamous cell carcinoma: a highly malignant form of esophageal cancer with SOX2 promoter hypermethylation.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2017

A long-term survival case after surgical resection of skeletal muscle metastasis following esophagectomy for squamous cell carcinoma of the esophagus.

Journal of surgical case reports
2017

Racial disparities in cancer-related survival in patients with squamous cell carcinoma of the esophagus in the US between 1973 and 2013.

PloS one
2017

Current trends in multimodality treatment of esophageal and gastroesophageal junction cancer - Review article.

Surgical oncology
2017

DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer.

Radiation oncology (London, England)
2017

Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinoma.

Molecular and clinical oncology
2018

Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy.

Gastroenterology
2017

Fibroblast activating protein-α expression in squamous cell carcinoma of the esophagus in primary and irradiated tumors: the use of archival FFPE material for molecular techniques.

European journal of histochemistry : EJH
2017

A novel gene expression scoring system for accurate diagnosis of basaloid squamous cell carcinoma of the esophagus.

International journal of oncology
2017

Squamous Cell Carcinoma of Oesophagus with Tracheo- Esophageal Fistula, Pulmonary Tuberculosis and Hyperthyroidism in 16 yrs Old Female.

The Journal of the Association of Physicians of India
2017

An isolated unusual digit metastasis from esophageal carcinoma: a case report.

OncoTargets and therapy
2017

Severe neutrophilic leukocytosis as a progression marker in granulocyte colony-stimulating factor-producing squamous cell carcinoma of the esophagus.

Clinical case reports
2017

Glycemic Status and Prognosis of Patients with Squamous Cell Carcinoma of the Esophagus.

World journal of surgery
2017

Endoscopic submucosal dissection and endoscopic mucosal resection for early stage esophageal cancer.

Annals of cardiothoracic surgery
2017

High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.

Thoracic cancer
2017

Bilateral approach for thoracoscopic esophagectomy with lymph node dissection in the dorsal area of the thoracic aorta in patients with esophageal cancer: A report of two cases.

International journal of surgery case reports
2017

Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus.

Medicine
Ver todos os 609 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Carcinoma de células escamosas esofágicas.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Carcinoma de células escamosas esofágicas e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É um tipo de tumor maligno do esôfago que se localiza mais frequentemente nos terços superior ou médio do órgão. É identificado na literatura médica pelas siglas CEC ou ESCC e catalogado sob o código CID-10 C15.4.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

6 publicações do grafo RarasNet (PubMed) · 5 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:99977
    Orphanet
  2. Q18556059
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Carcinoma de células escamosas esofágicas. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/carcinoma-de-celulas-escamosas-esofagicas

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Carcinoma de células escamosas esofágicas

ORPHA:99977 · MONDO:0005580
Prevalência
1-9 / 100 000
Herança
Multigenic/multifactorial, Not applicable
CID-10
C15.4 · Neoplasia maligna do terço médio do esôfago
CID-11
Ensaios
279 ativos
Início
Adult, Elderly
Prevalência
0.0 (Europe)
GARD
GARD:18901
MedGen
UMLS
C0279626
Repurposing
1 candidato
bleomycin — DNA synthesis inhibitor
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
NIH/GARD
fonte: GARD (NIH)
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Medicamentos aprovados FDA
fonte: FDA OpenFDA
Rara